3/16/2020, 6:22 PM (Source: TeleTrader)
more TeleTrader news


Chart for: Moderna

Moderna shares jump over 21% on vaccine progress

Stocks of American biotechnological company Moderna Inc. grew more than 21% on Monday as is it reported that the company began an experimental trial of a coronavirus vaccine. Scientists at the Kaiser Permanente Washington Research Institute in Seattle gave the first experimental shot to a 40-year old woman.

Director of the National Institute for Allergy and Infectious Diseases (NIH) Anthony Fauci stated that if the research goes well, a vaccine still won't be ready for public use in next 12 to 18 months. He added that finding a vaccine "is an urgent public health priority," and that this study that was "launched in record speed, is an important first step toward achieving that goal."

Moderna stock rose by 25.67% at 12:19 pm ET.

Breaking the News / TF